Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2536321 | European Journal of Pharmacology | 2007 | 22 Pages |
Abstract
This review gives a brief overview over the major aspects of application of the nicotine alkaloid and its close derivatives in the therapy of some neurodegenerative disorders and diseases (e.g. Alzheimer's disease, Parkinson's disease, Tourette's syndrome, schizophrenia etc.). The issues concerning methods of nicotine analysis and isolation, and some molecular aspects of nicotine pharmacology are included. The natural and synthetic analogues of nicotine that are considered for medical practice are also mentioned. The molecular properties of two naturally occurring nicotine enantiomers are compared — the less-common but less-toxic (R)-nicotine is suggested as a natural compound that may find its place in pharmaceutical practice.
Keywords
Related Topics
Life Sciences
Neuroscience
Cellular and Molecular Neuroscience
Authors
Dariusz Pogocki, Tomasz Ruman, Magdalena Danilczuk, Marek Danilczuk, Monika Celuch, Elżbieta Wałajtys-Rode,